Prenetics Global Limited, a consumer health company, focuses on empowering individuals to take control of their health through science-backed solutions in Hong Kong, Taiwan, the United States, and internationally. The company operates in three segments: Prevention, Diagnostics, and Consumer Health. It operates IM8 Health that sells health and wellness products; and provides fulfillment and distribution services for sports nutrition products under the Consumer Health segment. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into health, wellness, and genetic predispositions under Prevention segment.; and ACT Genomics that provides precision oncology testing services under the Diagnostics segment. In addition, it develops and commercializes multi-cancer early detection technologies. Further, the company offers a range of genomic profiling panels tailored for requirements and clinician needs. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Metrics to compare | PRE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPREPeersSector | |
---|---|---|---|---|
P/E Ratio | −2.1x | −1.0x | −0.5x | |
PEG Ratio | −0.07 | 0.01 | 0.00 | |
Price/Book | 0.6x | 0.8x | 2.6x | |
Price / LTM Sales | 2.5x | 0.6x | 3.3x | |
Upside (Analyst Target) | 88.7% | 45.7% | 43.3% | |
Fair Value Upside | Unlock | 19.8% | 6.9% | Unlock |